A nomogram based on age, prostate-specific antigen level, prostate volume and digital rectal examination for predicting risk of prostate cancer

被引:35
|
作者
Tang, Ping [1 ,2 ]
Chen, Hui [3 ]
Uhlman, Matthew [4 ]
Lin, Yu-Rong [2 ]
Deng, Xiang-Rong [2 ]
Wang, Bin [2 ]
Yang, Wen-Jun [2 ]
Xie, Ke-Ji [2 ]
机构
[1] So Med Univ, Postgrad Inst, Guangzhou 510515, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Guangzhou Municipal Peoples Hosp 1, Dept Urol, Guangzhou 510180, Guangdong, Peoples R China
[3] Guangdong Prov Work Injury Rehabil Hosp, Dept Urol, Guangzhou 510440, Guangdong, Peoples R China
[4] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA
基金
中国国家自然科学基金;
关键词
nomogram; prediction; prostate biopsy; prostate cancer; prostate-specific antigen (PSA); prostate volume (PV); age; digital rectal examination (DRE); BIOPSY OUTCOME PREDICTION; EXTERNAL VALIDATION; CALCULATOR; MORTALITY; MODELS; MEN;
D O I
10.1038/aja.2012.111
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Nomograms for predicting the risk of prostate cancer developed using other populations may introduce sizable bias when applied to a Chinese cohort. In the present study, we sought to develop a nomogram for predicting the probability of a positive initial prostate biopsy in a Chinese population. A total of 535 Chinese men who underwent a prostatic biopsy for the detection of prostate cancer in the past decade with complete biopsy data were included. Stepwise logistic regression was used to determine the independent predictors of a positive initial biopsy. Age, prostate-specific antigen (PSA), prostate volume (PV), digital rectal examination (DRE) status,% free PSA and transrectal ultrasound (TRUS) findings were included in the analysis. A nomogram model was developed that was based on these independent predictors to calculate the probability of a positive initial prostate biopsy. A receiver-operating characteristic curve was used to assess the accuracy of using the nomogram and PSA levels alone for predicting positive prostate biopsy. The rate for positive initial prostate biopsy was 41.7% (223/535). The independent variables used to predict a positive initial prostate biopsy were age, PSA, PV and DRE status. The areas under the receiver-operating characteristic curve for a positive initial prostate biopsy for PSA alone and the nomogram were 79.7% and 84.8%, respectively. Our results indicate that the risk of a positive initial prostate biopsy can be predicted to a satisfactory level in a Chinese population using our nomogram. The nomogram can be used to identify and counsel patients who should consider a prostate biopsy, ultimately enhancing accuracy in diagnosing prostate cancer. Asian Journal of Andrology (2013) 15, 129-133; doi:10.1038/aja.2012.111; published online 10 December 2012
引用
收藏
页码:129 / 133
页数:5
相关论文
共 50 条
  • [1] A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore
    Lee, Alvin
    Lim, Joel
    Gao, Xiao
    Liu, Lizhen
    Chia, Sing Joo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E348 - E355
  • [2] Estimation of prostate cancer risk on the basis of total and free prostate-specific antigen, prostate volume and digital rectal examination
    Finne, P
    Auvinen, A
    Aro, J
    Juusela, H
    Määttänen, L
    Rannikko, S
    Hakama, M
    Tammela, TLJ
    Stenman, UH
    EUROPEAN UROLOGY, 2002, 41 (06) : 619 - 626
  • [3] Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate-specific antigen, digital rectal examination and the prostate-specific antigen density based on digital rectal prostate volume category
    Morote, Juan
    Triquell, Marina
    Campistol, Miriam
    Abascal, Jose M.
    Servian, Pol
    Trilla, Enrique
    BJUI COMPASS, 2023, 4 (03): : 266 - 268
  • [4] Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
    MacKintosh, F. Roy
    Sprenkle, Preston C.
    Walter, Louise C.
    Rawson, Lori
    Karnes, R. Jeffrey
    Morrell, Christopher H.
    Kattan, Michael W.
    Nawaf, Cayce B.
    Neville, Thomas B.
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [5] The Value of Prostate-Specific Antigen-Age Volume Score in Predicting Prostate Cancer in Taiwan
    Lin, Chun-Hsuan
    Chang, Che-Wei
    Li, Wei-Ming
    Wen, Shen-Chen
    Huang, Shu-Pin
    Li, Ching-Chia
    Wu, Wen-Jeng
    Ke, Hung-Lung
    Lee, Yung-Chin
    Jhan, Jhen-Hao
    UROLOGICAL SCIENCE, 2020, 31 (04) : 163 - 169
  • [6] Early detection of prostate cancer in German urological practice by digital rectal examination and prostate-specific antigen
    Luboldt, HJ
    Hüsing, J
    Rübben, H
    Altwein, JE
    Bichler, KH
    Czaja, D
    Fornara, P
    Jöckel, KH
    Schalkhäuser, K
    Weissbach, L
    Wirth, M
    UROLOGE A, 2000, 39 (04): : 330 - 333
  • [7] PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF AN ABNORMAL DIGITAL RECTAL EXAMINATION
    LUI, PD
    TERRIS, MK
    HANEY, DJ
    CONSTANTINOU, CE
    STAMEY, TA
    BRITISH JOURNAL OF UROLOGY, 1994, 74 (03): : 337 - 340
  • [8] Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators
    Roobol, Monique J.
    van Vugt, Heidi A.
    Loeb, Stacy
    Zhu, Xiaoye
    Bul, Meelan
    Bangma, Chris H.
    van Leenders, Arno G. L. J. H.
    Steyerberg, Ewout W.
    Schroder, Fritz H.
    EUROPEAN UROLOGY, 2012, 61 (03) : 577 - 583
  • [9] Free prostate-specific antigen outperforms total prostate-specific antigen as a predictor of prostate volume in patients without prostate cancer
    Avci, Sinan
    Onen, Efe
    Caglayan, Volkan
    Kilic, Metin
    Sambel, Murat
    Oner, Sedat
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2020, 92 (01) : 1 - 6
  • [10] Prostate-specific antigen, digital rectal examination, and prostate cancer detection: A study based on more than 7000 transrectal ultrasound-guided prostate biopsies in Ghana
    Mensah, James Edward
    Akpakli, Evans
    Kyei, Mathew
    Klufio, Kenneth
    Asiedu, Isaac
    Asante, Kweku
    Toboh, Bernard
    Ashaley, Micheal Darko
    Addo, Ben Molai
    Morton, Bernard
    Quist, Erica Akoto
    TRANSLATIONAL ONCOLOGY, 2025, 51